预防对比剂诱导的急性肾损伤:瑞典-ESUR指南的并列比较
本文并列比较了瑞典泌尿放射学会(SSUR)与欧洲泌尿生殖放射学会(ESUR)关于对比剂诱导急性肾损伤(CI-AKI)的最新指南,主要差异包括SSUR采用更高的肾小球滤过率(GFR)阈值(<45 ml/min vs ESUR的<30 ml/min/1.73 m2)、继续考虑传统非肾脏危险因素、建议停用NSAID及肾毒性药物、采用绝对GFR值、将冠状动脉操作中的对比剂剂量/GFR比值阈值应用于增强CT,并建议高危患者碘克沙醇剂量/GFR比值<0.5,而ESUR无此推荐。
要点
- SSUR将CI-AKI危险因素及停用二甲双胍的GFR阈值定为<45 ml/min,而ESUR定为<30 ml/min/1.73 m2。
- SSUR继续推荐考虑糖尿病和充血性心力衰竭等传统非肾脏危险因素,ESUR认为这些因素对CI-AKI非特异而不推荐考虑。
- SSUR推荐高危患者碘剂量/GFR比值<0.5,ESUR无此推荐。
核心结论
- SSUR较ESUR采取更谨慎的态度,原因是当前关于CI-AKI风险的证据不足。
研究设计与样本
- 本文为瑞典泌尿放射学会(SSUR)与欧洲泌尿生殖放射学会(ESUR)关于对比剂诱导急性肾损伤(CI-AKI)指南的并列比较。
诊断标准与关键数值
- SSUR将CI-AKI危险因素及停用二甲双胍的GFR阈值定为<45 ml/min,ESUR定为<30 ml/min/1.73 m2(适用于静脉或动脉内对比剂注射且肾脏二次暴露时)。
- SSUR推荐考虑糖尿病和充血性心力衰竭等传统非肾脏危险因素,ESUR认为这些因素对CI-AKI非特异而不推荐考虑。
- 与ESUR不同,SSUR还推荐如有可能停用NSAID和肾毒性药物。
- SSUR以绝对GFR值(ml/min)表示阈值,ESUR使用按体表面积归一化的相对GFR(ml/min/1.73 m2)。
- SSUR将冠状动脉造影/介入中建立的对比剂剂量/GFR比值阈值作为增强CT的推荐,ESUR无此推荐。
临床应用与阅片要点
- SSUR推荐如有可能停用NSAID和肾毒性药物。
- SSUR推荐考虑糖尿病和充血性心力衰竭等传统非肾脏危险因素。
- SSUR将冠状动脉造影/介入中建立的对比剂剂量/GFR比值阈值作为增强CT的推荐。
- SSUR推荐CI-AKI风险患者碘剂量/GFR比值<0.5。
局限性
- 当前证据不足促使SSUR采取更谨慎的态度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
A side-by-side comparison of updated guidelines regarding contrast medium-induced acute kidney injury (CI-AKI) from the Swedish Society of Uroradiology (SSUR) and the European Society of Urogenital Radiology (ESUR) is presented. The major discrepancies include a higher glomerular filtration rate (GFR) threshold as a risk factor for CI-AKI and for discontinuation of metformin by SSUR, i.e., < 45 ml/min versus < 30 ml/min/1.73 m2 by ESUR, when intravenous or intra-arterial contrast media (CM) with second-pass renal exposure is administered. SSUR also continues to recommend consideration of traditional non-renal risk factors such as diabetes and congestive heart failure, while ESUR considers these factors as non-specific for CI-AKI and does not recommend any consideration. Contrary to ESUR, SSUR also recommends discontinuation of NSAID and nephrotoxic medication if possible. Insufficient evidence at the present time motivates the more cautionary attitude taken by SSUR. Furthermore, SSUR expresses GFR thresholds in absolute values in ml/min as recommended by the National Kidney Foundation for drugs excreted by glomerular filtration, while ESUR uses the relative GFR normalised to body surface area in ml/min/1.73 m2. CM dose/GFR ratio thresholds established for coronary angiography/interventions are also applied as recommendations for CM-enhanced CT by SSUR, since SSUR regards coronary procedures as a second-pass renal exposure of CM with no obvious difference in the incidence of AKI compared with IV CM administration. Finally, SSUR recommends reducing the gram-iodine dose/GFR ratio from < 1.0 in patients not at risk to < 0.5 in patients at risk of CI-AKI, while ESUR has no such recommendation. KEY POINTS: • The more cautionary attitude taken by SSUR compared with that of ESUR is motivated by insufficient evidence regarding risk for contrast medium-induced acute kidney injuries (CI-AKI). • SSUR recommends that absolute and not relative GFR should be used when dosing drugs eliminated by the kidneys such as contrast media. • According to SSUR the gram-iodine dose/GFR ratio should be < 0.5 in patients at risk of CI-AKI, while ESUR has no such recommendation.
引用
- Nyman U, Ahlkvist J, Aspelin P, et al. Preventing contrast medium-induced acute kidney injury : Side-by-side comparison of Swedish-ESUR guidelines. Eur Radiol. 2018. PMID: 30132106. doi:10.1007/s00330-018-5678-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。